Lv1
40 积分 2025-07-27 加入
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF -Mutant Melanoma
13天前
已完结
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
13天前
已完结
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
13天前
已完结
Risk factors for developing peritoneal metastases after curative surgery for colorectal cancer: A systematic review and meta‐analysis
26天前
已完结
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
26天前
已完结
Evidence for the effectiveness of digital health
27天前
已完结
New GRADE Evidence-to-Decision Framework for Pairwise and Multiple Comparisons (GRADE Guidance 45)
1个月前
已完结
Development and Validation of a Clinical Nomogram for Predicting Complications From Pediatric Multiple Magnet Ingestion: A Large Retrospective Study
1个月前
已完结
Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases
1个月前
已完结
Simultaneous resection for colorectal cancer with synchronous liver metastases: current state-of-the-art
1个月前
已完结
皖公网安备34019202002308
